TABLE 2.
Relationship of KYN metabolites with other inflammatory parameters in COVID‐19 patient and control groups and total cases
Group | TRP | KYN | KYN:TRP ratio | KYNA | 3OHKYN | QA | PA |
---|---|---|---|---|---|---|---|
N:L Ratio | |||||||
Total | −0.339* | 0.271* | 0.412* | 0.570* | 0.393* | 0.609* | 0.521* |
COVID‐19 | −0.184 | 0.074 | 0.129 | 0.373* | 0.384* | 0.374* | 0.185 |
Control | 0.083 | 0.026 | −0.018 | 0.023 | 0.303 | 0.116 | 0.211 |
LDH | |||||||
Total | −0.069 | 0.470* | 0.442* | 0.510* | 0.127 | 0.546* | 0.567* |
COVID‐19 | 0.260* | 0.271* | 0.029 | 0.034 | 0.016 | 0.009 | 0.250* |
Control | 0.007 | 0.068 | 0.165 | 0.116 | 0.044 | 0.027 | −0.067 |
Procalcitonin | |||||||
Total | −0.210* | 0.316* | 0.418* | 0.368* | 0.226* | 0.446* | 0.358* |
COVID−19 | −0.090 | 0.230 | 0.322* | 0.274* | 0.239* | 0.324* | 0.144 |
Control | −0.079 | −0.110 | 0.089 | −0.058 | 0.031 | 0.061 | 0.220 |
Troponin | |||||||
Total | −0.290* | 0.351* | 0.447* | 0.590* | 0.237* | 0.664* | 0.431* |
COVID‐19 | −0.105 | 0.027 | 0.083 | 0.344* | 0.244* | 0.283* | −0.103 |
Control | −0.087 | 0.056 | 0.097 | −0.136 | −0.140 | 0.082 | 0.247 |
D‐Dimer | |||||||
Total | −0.218* | 0.334* | 0.400* | 0.536* | 0.065 | 0.606* | 0.573* |
COVID‐19 | 0.118 | −0.037 | −0.182 | 0.069 | −0.153 | −0.013 | 0.104 |
Control | −0.181 | −0.132 | 0.089 | −0.101 | −0.046 | −0.100 | 0.086 |
Fibrinogen | |||||||
Total | −0.156 | 0.240* | 0.322* | 0.469* | 0.225* | 0.602* | 0.507* |
COVID‐19 | 0.103 | −0.139 | −0.176 | 0.018 | 0.169 | 0.159 | 0.110 |
Control | 0.242 | −0.110 | −0.208 | 0.132 | 0.057 | −0.086 | −0.113 |
CRP | |||||||
Total | −0.291* | 0.343* | 0.475* | 0.626* | 0.215* | 0.750* | 0.530* |
COVID‐19 | −0.081 | −0.089 | −0.067 | 0.216 | 0.200 | 0.336 | −0.004 |
Control | 0.079 | 0.268 | 0.231 | 0.220 | −0.152 | 0.259 | −0.125 |
IL‐6 | |||||||
Total | −0.384* | 0.442* | 0.599* | 0.498* | 0.295* | 0.682* | 0.524* |
COVID‐19 | −0.158 | 0.295* | 0.376* | 0.144 | 0.268* | 0.303* | 0.089 |
Control | −0.160 | 0.033 | 0.234 | −0.211 | −0.018 | 0.047 | 0.126 |
Ferritin | |||||||
Total | −0.185 | 0.503* | 0.517* | 0.630* | 0.212* | 0.655* | 0.584* |
COVID‐19 | 0.067 | 0.392* | 0.305* | 0.370* | 0.216 | 0.288* | 0.285* |
Control | 0.117 | −0.090 | −0.253 | 0.156 | −0.239 | −0.001 | −0.183 |
TRP | |||||||
Total | −0.024 | −0.528* | −0.229* | −0.303* | −0.433* | −0.179 | |
COVID‐19 | 0.187 | −0.388* | −0.172 | −0.285* | −0.317* | 0.138 | |
Control | 0.047 | −0.611* | 0.492* | −0.019 | −0.106 | −0.126 | |
KYN | |||||||
Total | 0.832* | 0.615* | 0.382* | 0.631* | 0.533* | ||
COVID‐19 | 0.800* | 0.503* | 0.319* | 0.481* | 0.441* | ||
Control | 0.691* | 0.357* | 0.371* | 0.566* | 0.168 | ||
KYN:TRP ratio | |||||||
Total | 0.604* | 0.432* | 0.765* | 0.545* | |||
COVID‐19 | 0.512* | 0.441* | 0.608* | 0.303* | |||
Control | −0.075 | 0.295* | 0.514* | 0.212 | |||
KYNA | |||||||
Total | 0.485* | 0.764* | 0.518* | ||||
COVID‐19 | 0.631* | 0.655* | 0.250* | ||||
Control | −0.036 | 0.070 | −0.017 | ||||
3OHKYN | |||||||
Total | 0.475* | 0.264* | |||||
COVID‐19 | 0.592* | 0.140 | |||||
Control | 0.242 | 0.279 | |||||
QA | |||||||
Total | 0.575* | ||||||
COVID‐19 | 0.147 | ||||||
Control | 0.159 |
Bold indicates statistically significant value (p < 0.05).